These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11973240)

  • 1. Validity of the time trade-off and standard gamble methods of utility assessment in retinal patients.
    Sharma S; Brown GC; Brown MM; Hollands H; Robins R; Shah GK
    Br J Ophthalmol; 2002 May; 86(5):493-6. PubMed ID: 11973240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of EuroQOL-5D, time trade-off, and standard gamble for age-related macular degeneration in the Singapore population.
    Au Eong KG; Chan EW; Luo N; Wong SH; Tan NW; Lim TH; Wagle AM
    Eye (Lond); 2012 Mar; 26(3):379-88. PubMed ID: 22222257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A utility analysis correlation with visual acuity: methodologies and vision in the better and poorer eyes.
    Brown MM; Brown GC; Sharma S; Smith AF; Landy J
    Int Ophthalmol; 2001; 24(3):123-7. PubMed ID: 12498507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with uveitis.
    Shamdas M; Bassilious K; Murray PI
    Br J Ophthalmol; 2019 Sep; 103(9):1284-1288. PubMed ID: 30361275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' preferences in treatment for neovascular age-related macular degeneration in clinical routine.
    Finger RP; Hoffmann AE; Fenwick EK; Wolf A; Kampik A; Kernt M; Neubauer AS; Hirneiss C
    Br J Ophthalmol; 2012 Jul; 96(7):997-1002. PubMed ID: 22535331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rating scale is a proper method to evaluate changes in quality of life due to dry eye symptoms.
    Xue W; Xu X; Zou H
    Int Ophthalmol; 2019 Mar; 39(3):563-569. PubMed ID: 29417445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of age-related macular degeneration on health status utility values.
    Espallargues M; Czoski-Murray CJ; Bansback NJ; Carlton J; Lewis GM; Hughes LA; Brand CS; Brazier JE
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4016-23. PubMed ID: 16249475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is utility-based quality of life in adults affected by glaucoma?
    Gothwal VK; Bagga DK; Rao HL; Bharani S; Sumalini R; Garudadri CS; Senthil S; Reddy SP; Pathak-Ray V; Mandal AK
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1361-9. PubMed ID: 24519425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of the visual function index (VF-14) in patients with retinal disease.
    Linder M; Chang TS; Scott IU; Hay D; Chambers K; Sibley LM; Weis E
    Arch Ophthalmol; 1999 Dec; 117(12):1611-6. PubMed ID: 10604665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported utilities in bilateral visual impairment from amblyopia and age-related macular degeneration.
    van de Graaf ES; Despriet DDG; Klaver CCW; Simonsz HJ
    BMC Ophthalmol; 2016 May; 16(1):56. PubMed ID: 27184381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility assessment among cataract surgery patients.
    Saw SM; Gazzard G; Gomezperalta C; Au Eong KG; Seah S
    J Cataract Refract Surg; 2005 Apr; 31(4):785-91. PubMed ID: 15899457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of persistent visually disabling vitreous floaters on health status utility values.
    Zou H; Liu H; Xu X; Zhang X
    Qual Life Res; 2013 Aug; 22(6):1507-14. PubMed ID: 23054488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Visual Field Clusters on Performance-based Measures and Vision-Related Quality of Life in Patients With Glaucoma.
    Sun Y; Lin C; Waisbourd M; Ekici F; Erdem E; Wizov SS; Hark LA; Spaeth GL
    Am J Ophthalmol; 2016 Mar; 163():45-52. PubMed ID: 26701273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility values among glaucoma patients: an impact on the quality of life.
    Gupta V; Srinivasan G; Mei SS; Gazzard G; Sihota R; Kapoor KS
    Br J Ophthalmol; 2005 Oct; 89(10):1241-4. PubMed ID: 16170108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construct validity of the interview time trade-off and computer time trade-off in patients with rheumatoid arthritis: a cross-sectional observational pilot study.
    Buitinga L; Braakman-Jansen LM; Taal E; van de Laar MA
    BMC Musculoskelet Disord; 2012 Jun; 13():112. PubMed ID: 22730908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilities associated with diabetic retinopathy: results from a Canadian sample.
    Sharma S; Oliver-Fernandez A; Bakal J; Hollands H; Brown GC; Brown MM
    Br J Ophthalmol; 2003 Mar; 87(3):259-61. PubMed ID: 12598432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility values and diabetic retinopathy.
    Brown MM; Brown GC; Sharma S; Shah G
    Am J Ophthalmol; 1999 Sep; 128(3):324-30. PubMed ID: 10511027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.